Insider Shareholders with Direct Ownership of Phase Bio Pharmaceuticals Inc (PHAS)
This section provides a comprehensive overview of the insiders with direct ownership of Phase Bio Pharmaceuticals Inc (PHAS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PhaseBio Pharmaceuticals Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 13 Lp
> 10% Shareholder |
0 | 1,784,109 | 4,857,525 $0 | 1 |
Oct 25, 2022
Reduced 26.86%
|
|
Jonathan P Mow
Chief Executive Officer |
64,148 | 0 | 132,502 $0 | 6 |
May 20, 2022
Added 7.61%
|
|
John P Sharp
Chief Financial Officer |
25,767 | 0 | 65,767 $0 | 6 |
May 20, 2022
Added 8.39%
|
|
Susan Elizabeth Arnold
SVP, Technical Operations |
38,930 | 0 | 41,236 $0 | 7 |
May 20, 2022
Added 20.93%
|
|
Nancy J Hutson
Director |
37,510 | 0 | 37,510 $0 | 3 |
May 19, 2023
Added 9.09%
|
|
Clay Thorp
Director |
20,894 | 0 | 36,693 $0 | 5 |
May 19, 2023
Added 9.27%
|
|
Jonathan Birchall
Chief Commercial Officer |
20,000 | 0 | 20,000 $0 | 1 |
May 20, 2022
Added 50.0%
|
|
Edmund Harrigan
Director |
9,750 | 0 | 9,750 $0 | 2 |
May 19, 2023
Added 27.78%
|
|
David James Ballance
VP, Research and Sci. Affairs |
919 | 0 | 8,519 $0 | 1 |
Nov 20, 2020
Added 9.74%
|
|
Kristopher Hanson
SVP and General Counsel |
8,463 | 0 | 8,463 $0 | 4 |
May 20, 2022
Added 36.34%
|
|
Michael York
VP, Corporate Development |
5,559 | 0 | 7,059 $0 | 2 |
May 20, 2021
Added 29.1%
|
|
Caroline M Loewy
Director |
3,750 | 0 | 3,750 $0 | 1 |
May 19, 2023
Added 50.0%
|
|
Alex Sapir
Director |
3,750 | 0 | 3,750 $0 | 1 |
May 19, 2023
Added 50.0%
|
|
William D. Humphries
Director |
2,538 | 0 | 2,538 $0 | 1 |
May 19, 2023
Added 50.0%
|
|
Glen Burkhardt
SVP of Human Resources |
24,322 | 24,322 | 0 $0 | 8 |
May 23, 2022
Reduced 100.0%
|
|
Richard Van Den Broek
Director |
3,750 | 0 | 0 $0 | 1 |
May 19, 2023
Added 100.0%
|